Northwire Canada EditionFriday, October 16, 2026

Sign in Subscribe

GOLD 4218.40 +1.2% SILVER 58.02 +1.5% COPPER 6.62 +1.0% OIL 95.43 −2.6% PALLADIUM 1129.75 +0.1% OMI 0.250 +0.0% BUFF 0.810 +3.9% FEO 0.650 +0.0% LIB 0.760 +5.6% NPR 0.630 +1.6% QZM 0.380 +0.0% BVA 0.750 −1.3% ONAU 0.540 +3.9% FMR 0.225 +0.0% GSVR 0.355 +4.4% PHNM 0.345 +1.5% SLG 5.68 −0.5% CASA 0.060 +0.0% DRY 0.225 +4.7% SOMA 0.550 −1.8% PWRO 0.025 +0.0% GOLD 4218.40 +1.2% SILVER 58.02 +1.5% COPPER 6.62 +1.0% OIL 95.43 −2.6% PALLADIUM 1129.75 +0.1% OMI 0.250 +0.0% BUFF 0.810 +3.9% FEO 0.650 +0.0% LIB 0.760 +5.6% NPR 0.630 +1.6% QZM 0.380 +0.0% BVA 0.750 −1.3% ONAU 0.540 +3.9% FMR 0.225 +0.0% GSVR 0.355 +4.4% PHNM 0.345 +1.5% SLG 5.68 −0.5% CASA 0.060 +0.0% DRY 0.225 +4.7% SOMA 0.550 −1.8% PWRO 0.025 +0.0%

Financings

Trulieve Completes Redemption of All US$368 Million 8.0% Senior Secured Notes due 2026

By The Northwire Desk — AI Analysis Dec 08, 2025 · 08:00 TRUL · 8.42 Trulieve Cannabis Corp.

TRUL · Price

Executive Summary

Trulieve Cannabis Corp. completed the full redemption of its US$368 million 8.0% senior secured notes due 2026.
Approximately US$373 million in cash was used, covering principal and accrued interest up to the redemption date (December 5, 2025).
The notes were delisted from the Canadian Securities Exchange as of December 5, 2025.

Key Details

Redemption amount: US$368,000,000 principal.
Cash outlay: Approximately US$373,000,000 (principal plus accrued/unpaid interest).
Interest rate on notes: 8.0% senior secured.
Maturity date of original notes: 2026.
Redemption date: December 5, 2025 (cash paid through that date).
CUSIP/ISIN: CUSIP 89788CAD6 / ISIN CA89788CAD61.
Trading symbol prior to redemption: TRUL.NT.U on the Canadian Securities Exchange.
Delisting: Notes ceased trading and were delisted as of December 5, 2025.
Additional information source: Odyssey Trust Company (provides further details on the redemption).

Notable Quotes

(No executive quotes included in the release.)

Read the original news release →

More from Trulieve Cannabis Corp.

Jul 01, 2026 · 08:10

Georgia expansion marks first sales, but revenue compression and margin pressure remain key headwinds.

Production / Operations Jun 09, 2026 · 08:00

Trulieve's $50M Buyback Signals Confidence, But 43% Run-Up Into the Print Caps Near-Term Upside

Other Jun 05, 2026 · 07:00

Trulieve’s NYSE Debut Cements First-Mover Advantage in Post‑Rescheduling U.S. Medical Cannabis, With Texas and Georgia Upside in Focus

Regulatory May 21, 2026 · 08:45

Trulieve Stabilizes Post-Rescheduling Rally as Domestication Vote Looms

Production / Operations May 13, 2026 · 16:30

Trulieve swaps Canadian roots for Delaware law, but the home-run catalyst still awaits a rulemaking hearing.

Other May 07, 2026 · 06:15

Trulieve Posts Profit as Cannabis Rescheduling Lifts Margins